White House to propose a second COVID-19 booster for the elderly

Everyone over 50 will be able to obtain a COVID-19 booster dose of the Pfizer-BioNTech or Moderna vaccines.

Several obstacles hinder the strategy since the administration must forecast when the next COVID-19 wave will impact the United States. Before the next wave strikes, the administration will want to get the second booster to the elderly, but not too soon, or the safety would weaken.

Other obstacles are how to communicate the strategy to the public and how long the second booster's coverage will be effective.


Last Monday, White House adviser Anthony Fauci predicted that COVID-19 instances would start to rise in the following weeks.

However, as the BA.2 variety begins to become the dominant strand in the United States, it is unknown how hazardous this wave will be in comparison to previous rises.

Case numbers in most nations have dropped dramatically since the Omicron wave, while in certain nations, rates have plateaued or begun to rise when limitations are lifted and security from previous dosages begins to disappear.

When opposed to those who only took one booster dosage, the first Israeli study mentioned by Pfizer and BioNTech found that the rates of confirmed infections were 2 times lower and rates of severe illness were 4 times lower among persons who had an extra booster dose.

Recent research has found that while a third mRNA vaccination treatment elevates antibody levels above those of the previous treatment, a fourth dose merely brings individuals' levels back to the same high level.

Several European countries, as well as Israel, have previously permitted second boosters for the most vulnerable people, such as the elderly and immunocompromised.